ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

Summary

This study is intended to explore and evaluate the pharmacodynamics and clinical efficacy of the ionic contra-viral therapy CLS003 in immunocompromised and immunocompetent patients with benign and premalignant HPV-induced genital lesions

Timeline

Start

2017-10-05

Primary completion

2018-10-30

Completion

2018-10-30

Drugs

Indications